Bd

BD, a US-based medical, precision, and optical instruments company, reported a total of approximately 7.46 billion kg CO2e in emissions for the 2025 reporting year. This includes Scope 1 emissions of approximately 178.77 million kg CO2e, Scope 2 market-based emissions of about 202.51 million kg CO2e, and significant Scope 3 emissions totalling approximately 6.69 billion kg CO2e.

For the 2024 reporting year, BD's total emissions were approximately 6.42 billion kg CO2e, with Scope 1 at about 181.95 million kg CO2e, Scope 2 market-based at approximately 229.86 million kg CO2e, and Scope 3 emissions at around 6.04 billion kg CO2e.

BD is committed to significant emissions reductions, aligning with the Science Based Targets initiative (SBTi). Their near-term targets include a 50% reduction in absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 2030, using a 2019 baseline. In the long term, BD aims to reduce absolute Scope 1 and 2 GHG emissions by 90% by 2050. Furthermore, the company has a long-term goal to reduce Scope 3 GHG emissions by 97% per unit of sold product by 2050, based on a 2021 baseline. BD has also committed to reaching net-zero GHG emissions across its entire value chain by FY 2050.

The company's climate commitments are integrated into its operations, with a focus on achieving carbon neutrality across direct operations by 2040. These targets are recognised as being aligned with a 1.5°C global emissions reduction pathway.